Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (3244)	3/30/2001 11:39:14 AM
From: Biomaven	Read Replies (1) \| Respond to of 52153

One of the interesting thing in biotech investing is the "decay time" after good-sounding news that has only long-term implications. In the darkest of times, you are lucky if the pop survives to the close. During the bubble, the pop mostly just stayed in the stock, waiting for the next piece of good news. Right now, news like this still has a pretty short half-life. Buying immediately after the pop is in my experience almost always a bad idea if you intend to hold the stock for a while, unless of course the market is in a very optimistic frame of mind. Peter